181 related articles for article (PubMed ID: 37370399)
1. Clinical Implications of Immune Checkpoints and the RANK/RANK-L Signaling Pathway in High-Grade Canine Mast Cell Tumors.
Talavera Guillén NC; Barboza de Nardi A; Noleto de Paiva F; Dias QC; Pinheiro Fantinatti A; Fávaro WJ
Animals (Basel); 2023 Jun; 13(12):. PubMed ID: 37370399
[TBL] [Abstract][Full Text] [Related]
2. Beclin-1 is a novel predictive biomarker for canine cutaneous and subcutaneous mast cell tumors.
Knight BJ; Wood GA; Foster RA; Coomber BL
Vet Pathol; 2022 Jan; 59(1):46-56. PubMed ID: 34521293
[TBL] [Abstract][Full Text] [Related]
3. Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells.
Hämäläinen S; Kareinen L; Sukura A; Kareinen I
Vet Pathol; 2022 Mar; 59(2):236-243. PubMed ID: 34894899
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity of p21, MMP-1 and CB2 receptor proteins in cutaneous canine mast cell tumours: an association with the three-tier grading system.
Bulak K; Kycko A; Śmiech A; Łopuszyński W
J Vet Res; 2023 Dec; 67(4):611-618. PubMed ID: 38130452
[TBL] [Abstract][Full Text] [Related]
5. Analysis of risk factors for canine mast cell tumors based on the Kiupel and Patnaik grading system among dogs with skin tumors.
Martins AL; Carvalho FF; Mesquita JR; Gärtner F; Amorim I
Open Vet J; 2021; 11(4):619-634. PubMed ID: 35070857
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis.
Fenger JM; Bear MD; Volinia S; Lin TY; Harrington BK; London CA; Kisseberth WC
BMC Cancer; 2014 Feb; 14():84. PubMed ID: 24517413
[TBL] [Abstract][Full Text] [Related]
7. Intranasal mast cell tumors: Clinical, immunohistochemical, and molecular features in 20 dogs.
Larsen E; Watson AM; Muñoz Gutiérrez JF
Vet Pathol; 2022 Nov; 59(6):915-921. PubMed ID: 35787192
[TBL] [Abstract][Full Text] [Related]
8. miRNA profiles of canine cutaneous mast cell tumours with early nodal metastasis and evaluation as potential biomarkers.
Zamarian V; Ferrari R; Stefanello D; Ceciliani F; Grieco V; Minozzi G; Chiti LE; Arigoni M; Calogero R; Lecchi C
Sci Rep; 2020 Nov; 10(1):18918. PubMed ID: 33144602
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Breed-Related Mast Cell Tumour Occurrence and Prognostic Significance of Clinical Features in a Defined Population of Dogs in West-Central Italy.
Pierini A; Lubas G; Gori E; Binanti D; Millanta F; Marchetti V
Vet Sci; 2019 Jun; 6(2):. PubMed ID: 31174330
[TBL] [Abstract][Full Text] [Related]
10. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis.
Scase TJ; Edwards D; Miller J; Henley W; Smith K; Blunden A; Murphy S
J Vet Intern Med; 2006; 20(1):151-8. PubMed ID: 16496935
[TBL] [Abstract][Full Text] [Related]
11. Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms.
De Vos S; Demeyere K; De Cock H; Devriendt N; Schwarzkopf I; Fortrie R; Roggeman T; Meyer E; De Spiegelaere W; de Rooster H
Res Vet Sci; 2022 Dec; 151():90-95. PubMed ID: 35872552
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages and tumor-infiltrating lymphocytes in canine cutaneous and subcutaneous mast cell tumors.
Bertola L; Pellizzoni B; Giudice C; Grieco V; Ferrari R; Chiti LE; Stefanello D; Manfredi M; De Zani D; Recordati C
Vet Pathol; 2024 Apr; ():3009858241244851. PubMed ID: 38647163
[TBL] [Abstract][Full Text] [Related]
13. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001).
Sfiligoi G; Rassnick KM; Scarlett JM; Northrup NC; Gieger TL
J Am Vet Med Assoc; 2005 Apr; 226(8):1368-74. PubMed ID: 15844431
[TBL] [Abstract][Full Text] [Related]
14. Sentinel Lymph Node Mapping with Indirect Lymphangiography for Canine Mast Cell Tumour.
De Bonis A; Collivignarelli F; Paolini A; Falerno I; Rinaldi V; Tamburro R; Bianchi A; Terragni R; Gianfelici J; Frescura P; Dolce G; Pagni E; Bucci R; Vignoli M
Vet Sci; 2022 Sep; 9(9):. PubMed ID: 36136700
[TBL] [Abstract][Full Text] [Related]
15. Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway.
Lv Y; Zhao Y; Wang X; Chen N; Mao F; Teng Y; Wang T; Peng L; Zhang J; Cheng P; Liu Y; Kong H; Chen W; Hao C; Han B; Ma Q; Zou Q; Chen J; Zhuang Y
J Immunother Cancer; 2019 Feb; 7(1):54. PubMed ID: 30808413
[TBL] [Abstract][Full Text] [Related]
16. Utility of flow cytometry in canine primary cutaneous and matched nodal mast cell tumor.
Sulce M; Marconato L; Martano M; Iussich S; Dentini A; Melega M; Miniscalco B; Riondato F
Vet J; 2018 Dec; 242():15-23. PubMed ID: 30503539
[TBL] [Abstract][Full Text] [Related]
17. Widespread mismatch repair protein expression in canine cutaneous mast cell tumors.
Munday JS; French AF; Gibson IR; Gwynne K
Vet Pathol; 2009 Mar; 46(2):227-32. PubMed ID: 19261633
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC.
Mahmoudian RA; Mozhgani S; Abbaszadegan MR; Mokhlessi L; Montazer M; Gholamin M
J Mol Histol; 2021 Jun; 52(3):597-609. PubMed ID: 33884540
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.
Webster JD; Yuzbasiyan-Gurkan V; Thamm DH; Hamilton E; Kiupel M
BMC Vet Res; 2008 Aug; 4():32. PubMed ID: 18700956
[TBL] [Abstract][Full Text] [Related]
20. Expression of Carboxypeptidase A3 and Tryptase as Markers for Lymph Node Metastasis of Canine Cutaneous Mast Cell Tumors.
Thaiwong T; Cirillo JV; Heller J; Kiupel M
Front Vet Sci; 2022; 9():815658. PubMed ID: 35237679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
